Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies
暂无分享,去创建一个
S. Franceschi | Y. Qiao | Jennifer S. Smith | J. Sellors | Xun Zhang | J. Belinson | F. Zhao | Q. Pan | Shangying Hu | A. Lewkowitz | Wen‐hua Zhang | Feng Chen | R. Wu | Li-Hui Wei | Long-yu Li | Qing‐Ming Zhang | Chang-Qing Li | Ai-Di Xu | Y. Qiao
[1] B. Thomsen,et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study , 2002, BMJ : British Medical Journal.
[2] C. Wen. China's plans to curb cervical cancer. , 2005, The Lancet. Oncology.
[3] Y. Qiao,et al. Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy , 2006, Journal of lower genital tract disease.
[4] M. Plummer,et al. Papillomavirus infection in rural women in southern India , 2005, British Journal of Cancer.
[5] Y. Qiao,et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. , 2004, American journal of obstetrics and gynecology.
[6] S. Franceschi,et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study , 2006, British Journal of Cancer.
[7] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[8] Jennifer S. Smith,et al. A Global Review of Age-Specific and Overall Prevalence of Cervical Lesions , 2010, International Journal of Gynecologic Cancer.
[9] Y. Qiao,et al. Inappropriate gold standard bias in cervical cancer screening studies , 2007, International journal of cancer.
[10] S. Franceschi,et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. , 2010, The Lancet. Oncology.
[11] G. Liang,et al. Epidemiologic Trends of Sexually Transmitted Diseases in China , 2000, Sexually transmitted diseases.
[12] Y. Qiao,et al. Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection , 2009, International journal of cancer.
[13] Diane Solomon,et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. , 2010, Journal of the National Cancer Institute.
[14] Helen Trottier,et al. The epidemiology of genital human papillomavirus infection. , 2006, Vaccine.
[15] M. Plummer,et al. Time since first sexual intercourse and the risk of cervical cancer , 2012, International journal of cancer.
[16] Martyn Plummer,et al. International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence , 2008, Cancer Epidemiology Biomarkers & Prevention.
[17] J. Cuzick,et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening , 2006, International journal of cancer.
[18] M Arbyn,et al. Worldwide burden of cervical cancer in 2008. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] S. Franceschi,et al. Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide , 2006, International journal of cancer.
[20] Richard Doll,et al. Cancer incidence in five continents : a technical report , 1966 .
[21] S. Wacholder,et al. The age‐specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen‐and‐treat strategies , 2012, International journal of cancer.
[22] H. Ng,et al. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies , 2010, International journal of cancer.
[23] S. Franceschi,et al. Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study , 2008, Cancer Epidemiology Biomarkers & Prevention.
[24] Y. Qiao,et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. , 2001, Gynecologic oncology.
[25] C. Wheeler,et al. Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2 , 2009, Obstetrics and gynecology.
[26] Karen Canfell,et al. The burden of cervical cancer in China: Synthesis of the evidence , 2012, International journal of cancer.
[27] M. Plummer,et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.
[28] S. Franceschi,et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. , 2008, Vaccine.
[29] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[30] J. Peto,et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort , 2004, British Journal of Cancer.
[31] Stephen S Raab,et al. Cervical cancer screening by simple visual inspection after acetic acid. , 2002, Obstetrics and gynecology.
[32] T. Wright,et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.
[33] J. Peto,et al. The cervical cancer epidemic that screening has prevented in the UK , 2004, The Lancet.
[34] S. Franceschi,et al. HUMAN PAPILLOMAVIRUS INFECTION AMONG WOMEN IN SOUTH AND NORTH VIETNAM , 2003 .
[35] Wei-Yuan Zhang,et al. A Population-based Study on the Risks of Cervical Lesion and Human Papillomavirus Infection among Women in Beijing, People's Republic of China , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[36] Y. Qiao,et al. Shanxi Province cervical cancer screening study II: Self‐sampling for high‐risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[37] P. Coursaget,et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. , 2003, The Journal of infectious diseases.
[38] David R. Scott,et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.